Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The role of immune cells in metabolism-related liver inflammation and development of Non-Alcoholic Steatohepatitis (NASH).
Rev. Endocr. Metab. Disord. 17, 29-39 (2016)
The low grade inflammatory state present in obesity promotes the progression of Non-Alcoholic Fatty Liver Disease (NAFLD). In Non-Alcoholic Steatohepatitis (NASH), augmented hepatic steatosis is accompanied by aberrant intrahepatic inflammation and exacerbated hepatocellular injury. NASH is an important disorder and can lead to fibrosis, cirrhosis and even neoplasia. The pathology of NASH involves a complex network of mechanisms, including increased infiltration of different subsets of immune cells, such as monocytes, T-lymphocytes and neutrophils, to the liver, as well as activation and in situ expansion of liver resident cells such as Kupffer cells or stellate cells. In this review, we summarize recent advances regarding understanding the role of the various cells of the innate and adaptive immunity in NASH development and progression, and discuss possible future therapeutic options and tools to interfere with disease progression.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
5.088
1.453
78
94
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Hepatic Stellate Cells (hsc) ; Kupffer Cells ; Non-alcoholic Steatohepatitis (nash) ; Obesity ; Steatosis ; T-regulatory Cells (tregs); Hepatic Stellate Cells; Regulatory T-cells; Adipose-tissue Inflammation; Diet-induced Obesity; Activation In-vivo; Collagen Type-i; High-fat Diet; Insulin-resistance; Kupffer Cells; Dendritic Cells
Sprache
englisch
Veröffentlichungsjahr
2016
HGF-Berichtsjahr
2016
ISSN (print) / ISBN
1389-9155
e-ISSN
1573-2606
Zeitschrift
Reviews in Endocrine & Metabolic Disorders
Quellenangaben
Band: 17,
Heft: 1,
Seiten: 29-39
Verlag
Springer
Verlagsort
Boston
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Pancreatic Islet Research (IPI)
POF Topic(s)
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502600-008
G-502600-012
G-502600-001
G-502600-012
G-502600-001
WOS ID
WOS:000376887800004
PubMed ID
26847547
Erfassungsdatum
2016-03-07